ProAssurance Co. (NYSE:PRA) Receives Consensus Recommendation of "Hold" from Analysts

Shares of ProAssurance Co. (NYSE:PRA - Get Free Report) have been given a consensus rating of "Hold" by the six ratings firms that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and one has assigned a buy recommendation to the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $21.00.

PRA has been the subject of a number of research reports. Citizens Jmp cut shares of ProAssurance from an "outperform" rating to a "market perform" rating in a research note on Thursday, April 3rd. Piper Sandler boosted their target price on shares of ProAssurance from $18.00 to $25.00 and gave the stock a "neutral" rating in a research note on Thursday, May 8th. Raymond James cut shares of ProAssurance from a "market perform" rating to an "underperform" rating in a research note on Thursday, April 10th. Wall Street Zen initiated coverage on shares of ProAssurance in a research note on Monday, May 19th. They set a "hold" rating for the company. Finally, Citigroup cut shares of ProAssurance to a "market perform" rating in a research note on Thursday, April 3rd.

Institutional Trading of ProAssurance

Several large investors have recently bought and sold shares of the business. Mariner LLC grew its stake in ProAssurance by 4.2% during the 4th quarter. Mariner LLC now owns 17,007 shares of the insurance provider's stock valued at $271,000 after acquiring an additional 688 shares in the last quarter. CWM LLC grew its stake in ProAssurance by 95.9% during the 1st quarter. CWM LLC now owns 2,204 shares of the insurance provider's stock valued at $51,000 after acquiring an additional 1,079 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in ProAssurance by 4.0% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 28,991 shares of the insurance provider's stock valued at $461,000 after acquiring an additional 1,127 shares in the last quarter. Rhumbline Advisers grew its stake in ProAssurance by 0.8% during the 4th quarter. Rhumbline Advisers now owns 160,707 shares of the insurance provider's stock valued at $2,557,000 after acquiring an additional 1,281 shares in the last quarter. Finally, Sterling Capital Management LLC grew its stake in ProAssurance by 859.4% during the 4th quarter. Sterling Capital Management LLC now owns 1,631 shares of the insurance provider's stock valued at $26,000 after acquiring an additional 1,461 shares in the last quarter. Hedge funds and other institutional investors own 85.58% of the company's stock.

ProAssurance Stock Performance

NYSE PRA traded up $0.04 on Tuesday, reaching $23.19. 475,927 shares of the company's stock traded hands, compared to its average volume of 456,850. The firm has a market cap of $1.19 billion, a price-to-earnings ratio of 27.94 and a beta of 0.04. The stock has a 50 day moving average price of $23.15 and a 200-day moving average price of $18.44. ProAssurance has a fifty-two week low of $10.76 and a fifty-two week high of $23.70. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.28 and a current ratio of 0.28.

ProAssurance (NYSE:PRA - Get Free Report) last posted its earnings results on Tuesday, May 6th. The insurance provider reported $0.13 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.19 by ($0.06). ProAssurance had a net margin of 3.71% and a return on equity of 2.65%. The business had revenue of $236.28 million for the quarter, compared to analyst estimates of $272.85 million. During the same quarter in the prior year, the firm earned $0.08 earnings per share. The company's revenue for the quarter was down 4.5% on a year-over-year basis. Equities research analysts predict that ProAssurance will post 0.8 EPS for the current fiscal year.

ProAssurance Company Profile

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.